RAVI YANG SARIN - 17 Mar 2023 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Ravi Yang Sarin
Issuer symbol
TOI
Transactions as of
17 Mar 2023
Net transactions value
$0
Form type
4
Filing time
21 Mar 2023, 20:52:18 UTC
Previous filing
21 Nov 2022
Next filing
20 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Award $0 +29,528 +64% $0.000000 75,427 17 Mar 2023 Direct F1
holding TOI Common stock 4,109,771 17 Mar 2023 LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on March 16, 2024, subject to continued service with the Company through such vesting date.